WHO ICTRP trial
A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the…
EUCTR2017-002237-29-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002237-29-HU |
|---|---|
| Public title | A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects with Acute Myeloid Leukemia who are 60 Years or Older - The BATTLE Study |
| Scientific title | A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects with Acute Myeloid Leukemia who are 60 Years or Older - The BATTLE Study |
| Primary sponsor | BioLineRx, Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Czech Republic;Hungary;Slovakia;Poland;Spain;Israel |
| Conditions | Acute Myeloid Leukemia;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: BL-8040 Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Not available CAS Number: 664334-36-5 Current Sponsor code: BL-8040 Other descriptive name: BKT140; 4F-benzoyl-TN14003 Concentration unit… |
| Registration date | Mar 10, 2017 |
| Target size | 60 |
| Secondary IDs | BL-8040.AML.202 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: